Bupivacaine-induced apoptosis independently of WDR35 expression in mouse neuroblastoma Neuro2a cells

BMC Neuroscience

Volumn 13, Issue 1, 2012, Pages

  Harato, Misako ^a   Huang, Lei ^a   Kondo, Fumio ^a   Tsunekawa, Koji ^a   Feng, Guo Gang ^a   Fan, Jun Hua ^a   Ishikawa, Naohisa ^a   Fujiwara, Yoshihiro ^a   Okada, Shoshiro ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Bupivacaine; Neuro2a cells; P38 MAPK; Reactive oxygen species; WDR35

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTIOXIDANT; BUPIVACAINE; CASPASE 3; HYDROGEN PEROXIDE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; REACTIVE OXYGEN METABOLITE; SMALL INTERFERING RNA; TUMOR PROTEIN; UNCLASSIFIED DRUG; WDR35 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL ACTIVATION; CELL DEATH; CONCENTRATION RESPONSE; CONTROLLED STUDY; GENETIC TRANSFECTION; MOUSE; NEUROBLASTOMA CELL; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION;

ANESTHETICS, LOCAL; ANIMALS; ANTIOXIDANTS; APOPTOSIS; BUPIVACAINE; CASPASE 3; CELL DEATH; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; ETHYLENEDIAMINES; GENE EXPRESSION; HYDROGEN PEROXIDE; IMIDAZOLES; MICE; ORGANOMETALLIC COMPOUNDS; OXIDANTS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEINS; PYRIDINES; REACTIVE OXYGEN SPECIES; RNA, SMALL INTERFERING;

EID: 84872197183     PISSN: None     EISSN: 14712202     Source Type: Journal    
DOI: 10.1186/1471-2202-13-149     Document Type: Article

References (27)

1. Perez-Castro R, Patel S, Garavito-Aguilar ZV, Rosenberg A, Recio-Pinto E, Zhang J, Blanck TJ, Xu F. Cytotoxicity of local anesthetics in human neuronal cells. Anesth Analg 2009, 108:997-1007. 10.1213/ane.0b013e31819385e1, 19224816.
2. Auroy Y, Narchi P, Messiah A, Litt L, Rouvier B, Samii K. Serious complications related to regional anesthesia: results of a prospective survey in France. Anesthesiology 1997, 87:479-486. 10.1097/00000542-199709000-00005, 9316950.
3. Radwan IA, Saito S, Goto F. The neurotoxicity of local anesthetics on growing neurons: a comparative study of lidocaine, bupivacaine, mepivacaine, and ropivacaine. Anesth Analg 2002, 94:319-324.
4. Werdehausen R, Fazeli S, Braun S, Hermanns H, Essmann F, Hollmann MW, Bauer I, Stevens MF. Apoptosis induction by different local anaesthetics in a neuroblastoma cell line. Br J Anaesth 2009, 103:711-718. 10.1093/bja/aep236, 19700777.
5. Cuadrado A, Nebreda AR. Mechanisms and functions of p38 MAPK signalling. Biochem J 2010, 429:403-417. 10.1042/BJ20100323, 20626350.
6. Harper SJ, LoGrasso P. Signalling for survival and death in neurones: the role of stress-activated kinases, JNK and p38. Cell Signal 2001, 13:299-310. 10.1016/S0898-6568(01)00148-6, 11369511.
7. Park CJ, Park SA, Yoon TG, Lee SJ, Yum KW, Kim HJ. Bupivacaine induces apoptosis via ROS in the Schwann cell line. J Dent Res 2005, 84:852-857. 10.1177/154405910508400914, 16109997.
8. Lirk P, Haller I, Colvin HP, Lang L, Tomaselli B, Klimaschewski L, Gerner P. In vitro, inhibition of mitogen-activated protein kinase pathways protects against bupivacaine- and ropivacaine-induced neurotoxicity. Anesth Analg 2008, 106:1456-1464. 10.1213/ane.0b013e318168514b, 18420860.
9. Lu J, Xu SY, Zhang QG, Xu R, Lei HY. Bupivacaine induces apoptosis via mitochondria and p38 MAPK dependent pathways. Eur J Pharmacol 2011, 657:51-58. 10.1016/j.ejphar.2011.01.055, 21315711.
10. Neer EJ, Schmidt CJ, Nambudripad R, Smith TF. The ancient regulatory-protein family of WD-repeat proteins. Nature 1994, 371:297-300. 10.1038/371297a0, 8090199.
11. Smith TF, Gaitatzes C, Saxena K, Neer EJ. The WD repeat: a common architecture for diverse functions. Trends Biochem Sci 1999, 24:181-185. 10.1016/S0968-0004(99)01384-5, 10322433.
12. Mill P, Lockhart PJ, Fitzpatrick E, Mountford HS, Hall EA, Reijns MA, Keighren M, Bahlo M, Bromhead CJ, Budd P, Aftimos S, Delatycki MB, Savarirayan R, Jackson IJ, Amor DJ. Human and mouse mutations in WDR35 cause short-rib polydactyly syndromes due to abnormal ciliogenesis. Am J Hum Genet 2011, 88:508-515. 10.1016/j.ajhg.2011.03.015, 3071922, 21473986.
13. Feng GG, Li C, Huang L, Tsunekawa K, Sato Y, Fujiwara Y, Komatsu T, Honda T, Fan JH, Goto H, Koide T, Hasegawa T, Ishikawa N. Naofen, a novel WD40-repeat protein, mediates spontaneous and tumor necrosis factor-induced apoptosis. Biochem Biophys Res Commun 2010, 394:153-157. 10.1016/j.bbrc.2010.02.133, 20193664.
14. Fan JH, Feng GG, Huang L, Tsunekawa K, Honda T, Katano Y, Hirooka Y, Goto H, Kandatsu N, Ando K, Fujiwara Y, Koide T, Okada S, Ishikawa N. Role of naofen in apoptosis of hepatocytes induced by lipopolysaccharide through mitochondrial signaling in rats. Hepatol Res 2012, 42:696-705. 10.1111/j.1872-034X.2012.00972.x, 22409254.
15. Unami A, Shinohara Y, Ichikawa T, Baba Y. Biochemical and microarray analyses of bupivacaine-induced apoptosis. J Toxicol Sci 2003, 28:77-94. 10.2131/jts.28.77, 12820540.
16. Werdehausen R, Braun S, Essmann F, Schulze-Osthoff K, Walczak H, Lipfert P, Stevens MF. Lidocaine induces apoptosis via the mitochondrial pathway independently of death receptor signaling. Anesthesiology 2007, 107:136-143. 10.1097/01.anes.0000268389.39436.66, 17585225.
17. Gonzalez PK, Zhuang J, Doctrow SR, Malfroy B, Benson PF, Menconi MJ, Fink MP. EUK-8, a synthetic superoxide dismutase and catalase mimetic, ameliorates acute lung injury in endotoxemic swine. J Pharmacol Exp Ther 1995, 275:798-806.
18. Bruce AJ, Malfroy B, Baudry M. Beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger. Proc Natl Acad Sci USA 1996, 93:2312-2316. 10.1073/pnas.93.6.2312, 39792, 8637869.
19. Kawakami S, Matsuda A, Sunagawa T, Noda Y, Kaneko T, Tahara S, Hiraumi Y, Adachi S, Matsui H, Ando K, Fujita T, Maruyama N, Shirasawa T, Shimizu T. Antioxidant, EUK-8, prevents murine dilated cardiomyopathy. Circ J 2009, 73:2125-2134. 10.1253/circj.CJ-09-0204, 19749480.
20. Kennedy KA, Sandiford SD, Skerjanc IS, Li SS. Reactive oxygen species and the neuronal fate. Cell Mol Life Sci 2012, 69:215-221. 10.1007/s00018-011-0807-2, 21947442.
21. Lu X, Wang L, Chen S, He L, Yang X, Shi Y, Cheng J, Zhang L, Gu CC, Huang J, Wu T, Ma Y, Li J, Cao J, Chen J, Ge D, Fan Z, Li Y, Zhao L, Li H, Zhou X, Chen L, Liu D, Chen J, Duan X, Hao Y, Wang L, Lu F, Liu Z, Yao C, et al. Genome-wide association study in Han Chinese identifies four new susceptibility loci for coronary artery disease. Nat Genet 2012, 44:890-894. 10.1038/ng.2337, 22751097.
22. Bacino CA, Dhar SU, Brunetti-Pierri N, Lee B, Bonnen PE. WDR35 mutation in siblings with Sensenbrenner syndrome: A ciliopathy with variable phenotype. Am J Med Genet A 2012, 158:2917-2924.
23. Sato Y, Feng GG, Huang L, Fan JH, Li C, An J, Tsunekawa K, Kurokawa S, Fujiwara Y, Komatsu T, Kondo F, Ishikawa N. Enhanced expression of naofen in kidney of streptozotocin-induced diabetic rats: possible correlation to apoptosis of tubular epithelial cells. Clin Exp Nephrol 2010, 14:205-212. 10.1007/s10157-010-0276-1, 20224876.
24. Lee SJ, Shin TJ, Kang IS, Ha JH, Lee SC, Kim HJ. AMPK attenuates bupivacaine-induced neurotoxicity. J Dent Res 2010, 89:797-801. 10.1177/0022034510366823, 20448244.
25. Lu J, Xu SY, Zhang QG, Lei HY. Bupivacaine induces reactive oxygen species production via activation of the AMP-activated protein kinase-dependent pathway. Pharmacology 2011, 87:121-129. 10.1159/000323402, 21304223.
26. Wang Z, Shen J, Wang J, Lu T, Li C, Zhang X, Liu L, Ding Z. Lithium attenuates bupivacaine-induced neurotoxicity in vitro through phosphatidylinositol-3-kinase/threonine-serine protein kinase B- and extracellular signal-regulated kinase-dependent mechanisms. Neuroscience 2012, 206:190-200.
27. Huang L, Hotta Y, Miyazeki K, Ishikawa N, Miki Y, Sugimoto Y, Yamada J, Nakano A, Hishiwaki K, Shimada Y. Different effects of optical isomers of the 5-HT1A receptor antagonist pyrapyridolol against postischemic guinea-pig myocardial dysfunction and apoptosis through the mitochondrial permeability transition pore. Eur J Pharmacol 2006, 534:165-177. 10.1016/j.ejphar.2006.01.040, 16612842.